IL10 and colitis: Lactococcus lactis-secreting IL-10 [200], elafin (a human protease inhibitor) [201], and IL-27 (an immunosuppressive cytokine) [202] reportedly have anti-inflammatory effects in colitis models and may therefore represent potential candidates for future clinical trials.